IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
Stock Information for NYSE LISTED TEST STOCK FOR CTS AND CQS
Loading
Please wait while we load your information from QuoteMedia.